SEC Form 4 research
| Issuer | NEUROONE MEDICAL TECHNOLOGIES Corp |
|---|---|
| Tickers | NMTC, OSOK, OSEO |
| Reporting owners | 27 |
| Officers and directors | 6 |
| Last public filing | 2026-09-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-08-27 | Wambeke David J. | P | 33,333 | $2.01 | Not reported |
| 2026-09-08 | 2026-08-28 | Wambeke David J. | A | 35,000 | $0 | Not reported |
| 2026-08-28 | 2026-08-28 | Johns Emily J. | A | 12,500 | $0 | Not reported |
| 2026-08-28 | 2026-08-28 | Volker Christopher | A | 35,000 | $0 | Not reported |
| 2026-08-28 | 2026-08-28 | Mertens Steve | A | 15,000 | $0 | Not reported |
| 2026-08-28 | 2026-08-28 | Christianson Mark | A | 12,500 | $0 | Not reported |
| 2026-08-28 | 2026-08-28 | Rosa David A | A | 68,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.